Literature DB >> 19822367

Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation.

Hsien-Jen Cheng1, Huan-Yao Lei, Chiou-Feng Lin, Yueh-Hsia Luo, Shu-Wen Wan, Hsiao-Sheng Liu, Trai-Ming Yeh, Yee-Shin Lin.   

Abstract

Hemorrhagic syndrome is a hallmark of severe dengue diseases. We previously suggested a mechanism of molecular mimicry in which antibodies against dengue virus (DV) nonstructural protein 1 (NS1) cross-react with platelets. In the present study, we demonstrate that protein disulfide isomerase (PDI) on the platelet surface is recognized by anti-DV NS1 antibodies. Anti-DV NS1 obtained from hyperimmunized mouse sera inhibited PDI activity and platelet aggregation, and both inhibitory effects were prevented when anti-DV NS1 antibodies were preabsorbed with PDI. Anti-PDI antibodies bound to a peptide consisting of amino acid residues 311-330 (P311-330) of NS1. This peptide was a predicted epitope analyzed by homologous sequence alignments between DV NS1 and PDI. The platelet binding activities of anti-PDI and anti-DV NS1 antibodies were both reduced by P311-330 preabsorption. Similar to the findings using anti-DV NS1, antibodies against P311-330 bound to PDI and platelets, followed by inhibition of PDI activity and platelet aggregation. Furthermore, the cross-reactivity of dengue hemorrhagic fever patient sera with platelets was reduced when patient sera were preabsorbed with PDI or P311-330. Dengue hemorrhagic fever patient sera also inhibited platelet aggregation, while PDI or P311-330 reduced this inhibitory effect. In conclusion, anti-DV NS1 antibodies cross-react with PDI on platelet surface causing inhibition of platelet aggregation, which may provide implications in dengue disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822367     DOI: 10.1016/j.molimm.2009.08.033

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  36 in total

1.  Suppressive effect of dengue virus envelope protein domain III on megakaryopoiesis.

Authors:  Guan-Ling Lin; Hsin-Hou Chang; Te-Sheng Lien; Po-Kong Chen; Hao Chan; Mei-Tzu Su; Chi-Yuan Liao; Der-Shan Sun
Journal:  Virulence       Date:  2017-07-20       Impact factor: 5.882

2.  Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients.

Authors:  Hsien-Jen Cheng; Yueh-Hsia Luo; Shu-Wen Wan; Chiou-Feng Lin; Shan-Tair Wang; Nguyen Thanh Hung; Ching-Chuan Liu; Tzong-Shiann Ho; Hsiao-Sheng Liu; Trai-Ming Yeh; Yee-Shin Lin
Journal:  Am J Trop Med Hyg       Date:  2015-03-09       Impact factor: 2.345

3.  Dengue virus binding and replication by platelets.

Authors:  Ayo Y Simon; Michael R Sutherland; Edward L G Pryzdial
Journal:  Blood       Date:  2015-05-05       Impact factor: 22.113

4.  Molecular mimicry between dengue virus and coagulation factors induces antibodies to inhibit thrombin activity and enhance fibrinolysis.

Authors:  Yung-Chun Chuang; Yee-Shin Lin; Hsiao-Sheng Liu; Trai-Ming Yeh
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

5.  Adult-onset, chronic, cyclic thrombocytopenia in a Rhesus macaque (Macaca mulatta) after dengue virus vaccination and viral challenge.

Authors:  Galit H Frydman; Kelly A Metcalf Pate; Robert P Marini; Armelle M de Laforcade; Irene Bosch; Vasudevan Bakthavatchalu; Sureshkumar Muthupalani; Alton G Swennes; Claire E Lyons; Ronald G Tompkins; James G Fox
Journal:  Vet Clin Pathol       Date:  2017-05-18       Impact factor: 1.180

6.  A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.

Authors:  Magot Diata Omokoko; Sabar Pambudi; Supranee Phanthanawiboon; Promsin Masrinoul; Chayanee Setthapramote; Tadahiro Sasaki; Motoki Kuhara; Pongrama Ramasoota; Akifumi Yamashita; Itaru Hirai; Kazuyoshi Ikuta; Takeshi Kurosu
Journal:  Am J Trop Med Hyg       Date:  2014-04-28       Impact factor: 2.345

7.  A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.

Authors:  Grace K Tan; Jowin K W Ng; Scott L Trasti; Wouter Schul; George Yip; Sylvie Alonso
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

Review 8.  The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.

Authors:  Dustin R Glasner; Henry Puerta-Guardo; P Robert Beatty; Eva Harris
Journal:  Annu Rev Virol       Date:  2018-07-25       Impact factor: 10.431

9.  Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)-10 by monocytes.

Authors:  T N Adikari; L Gomes; N Wickramasinghe; M Salimi; N Wijesiriwardana; A Kamaladasa; N L A Shyamali; G S Ogg; G N Malavige
Journal:  Clin Exp Immunol       Date:  2016-01-19       Impact factor: 4.330

10.  Expression, purification, and evaluation of diagnostic potential and immunogenicity of a recombinant NS3 protein from all serotypes of dengue virus.

Authors:  Laura Mónica Alvarez-Rodríguez; Angel Ramos-Ligonio; José Luis Rosales-Encina; María Teresa Martínez-Cázares; Aurora Parissi-Crivelli; Aracely López-Monteon
Journal:  J Trop Med       Date:  2012-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.